VECTUS BIOSYSTEMS LIMITED — Director's Dealing 2016

Dec 4, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Karen Annette Duggan
Date of last notice	29 February 2016 (i.e. Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ajjika Technology Pty Limited Karen Annette Duggan is the sole shareholder of the trustee, Ajjika Technology Pty Limited, and she is the beneficiary of the trust i.e. The Ajjika A/C.
Date of change	5 December 2016
No. of securities held prior to change	1,500 fully paid ordinary shares held in the name of Karen Duggan, escrowed until 23 February 2018. 3,200,000 fully paid ordinary shares, escrowed until 23 February 2018, held in the name of Ajjika Technology Pty Limited
Class	Performance Rights, Deferred Share Awards and fully paid ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired	100,000 Performance Rights 75,000 Deferred Share Awards 2,000 fully paid ordinary shares
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Issued following shareholder approval at the Company’s 17 November 2016 Annual General Meeting (AGM). Details of the estimated valuation are set out on pages 6 to 9 of the Notice of AGM.
No. of securities held after change	1,500 fully paid ordinary shares held in the name of Karen Duggan, escrowed until 23 February 2018. 2,000 fully paid ordinary shares held in the name of Karen Duggan. 75,000 Deferred Share Awards under the Vectus Employee Incentive Plan in the name of Karen Duggan. These Deferred Share Awards expire on 17 November 2019 if not converted into shares after meeting performance conditions. 100,000 performance rights under the Vectus Employee Incentive Plan in the name of Karen Duggan. These performance rights expire on 5 December 2018 if not converted into shares after meeting performance conditions. 3,200,000 fully paid ordinary shares, escrowed until 23 February 2018, held in the name of Ajjika Technology Pty Limited
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Performance Rights, Deferred Share Awards and fully paid ordinary shares issued following shareholder approval at the Company’s 17 November 2016 AGM.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not Applicable
Nature of interest	Not Applicable
Name of registered holder (if issued securities)	Not Applicable
Date of change	Not Applicable
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Not Applicable
Interest acquired	Not Applicable
Interest disposed	Not Applicable
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Not Applicable
Interest after change	Not Applicable

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded No during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Maurie Stang
Date of last notice	26 February 2016 (i.e. Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Energy Trading Systems Pty Ltd Maurie Stang is the sole shareholder of the trustee, Energy Trading Systems Pty Ltd, and he is a beneficiary of The MPF Trust. Mr Bernard Stang & Mr Maurie Stang Maurie Stang and Bernard Stang are 50% each holders in the trust. Maurie Stang and Bernard Stang are 50% each shareholders of each of the following companies: Stangcorp Pty Ltd Epitek Corporation Pty Ltd 247 Church Street Pty Ltd Brunswick Property Pty Ltd Ramlist Pty Ltd Regional Health Care Group Pty Ltd Teknik PtyLtd
Date of change	5 December 2016

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	2,550,000 fully paid ordinary shares, escrowed until 23 February 2018, in the name of Energy Trading Systems Pty Ltd 1,500 fully paid ordinary shares in the name of Mr Bernard Stang & Mr Maurie Stang 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Brunswick Property Pty Ltd 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik Pty Ltd
Class	Performance Rights
Number acquired	100,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Performance Rights issued following shareholder approval at the Company’s 17 November 2016 Annual General Meeting (AGM). Details of the estimated valuation are set out on pages 6 and 7 of the Notice of AGM.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

2,550,000 fully paid ordinary shares, escrowed until 23 February 2018, in the name of Energy Trading Systems Pty Ltd 100,000 performance rights in the name of Maurie Stang under the Vectus Employee Incentive Plan. These performance rights expire on 5 December 2018 if not converted into shares after meeting performance conditions. 1,500 fully paid ordinary shares in the name of Mr Bernard Stang & Mr Maurie Stang 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Brunswick Property Pty Ltd 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik PtyLtd

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Performance Rights issued following shareholder approval at the Company’s 17 November 2016 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not Applicable
Nature of interest	Not Applicable
Name of registered holder (if issued securities)	Not Applicable
Date of change	Not Applicable
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Not Applicable
Interest acquired	Not Applicable
Interest disposed	Not Applicable
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Not Applicable
Interest after change	Not Applicable

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded No during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Peter Bush
Date of last notice	26 February 2016 (i.e. Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ms Sarah Bush (wife of Peter Bush) Dillon Ventures Pty Ltd (Peter Bush and Sarah Bush each hold 50% of the shares in Dillon Ventures Pty Ltd.) Dillon Ventures Pty Ltd (Peter Bush and Sarah Bush each hold 50% of the shares of the trustee, Dillon Ventures Pty Ltd, and they are both the beneficiaries of the trust i.e. The Dillon Ventures A/C.)
Date of change	5 December 2016

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	1,300 fully paid ordinary shares in the name of Peter Bush 1,300 fully paid ordinary shares in the name of Ms Sarah Bush 1,300 fully paid ordinary shares in the name of Dillon Ventures Pty Ltd 100,000 performance rights, escrowed until 23 February 2018 under the Vectus Employee Incentive Plan (EIP), in the name of Dillon Ventures Pty Ltd Ventures A/C> . These performance rights expire, if not converted into shares after meeting performance conditions, on 23 February2019.
Class	Performance Rights
Number acquired	100,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Performance Rights issued following shareholder approval at the Company’s 17 November 2016 Annual General Meeting (AGM). Details of the estimated valuation are set out on pages 6 and 7 of the Notice of AGM.
No. of securities held after change	1,300 fully paid ordinary shares in the name of Peter Bush 100,000 performance rights under the Vectus EIP in the name of Peter Bush. These performance rights expire on 5 December 2018 if not converted into shares after meeting performance conditions. 1,300 fully paid ordinary shares in the name of Ms Sarah Bush 1,300 fully paid ordinary shares in the name of Dillon Ventures Pty Ltd 100,000 performance rights, escrowed until 23 February 2018 under the Vectus Employee Incentive Plan (EIP), in the name of Dillon Ventures Pty Ltd . These performance rights expire, if not converted into shares after meeting performance conditions, on 23 February 2019.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Performance Rights issued following shareholder approval at the Company’s 17 November 2016 AGM.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not Applicable
Nature of interest	Not Applicable
Name of registered holder (if issued securities)	Not Applicable
Date of change	Not Applicable
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Not Applicable
Interest acquired	Not Applicable
Interest disposed	Not Applicable
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Not Applicable
Interest after change	Not Applicable

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded No during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3